AblesAZ, NagubilliR: Prevention, diagnosis and management of serotonin syndrome. Am Fam Physician, 2010; 81:1139–1142.
2.
BrownTM, SkopBP, MarethTR: Pathophysiology and management of the serotonin syndrome. Ann Pharmacother, 1996; 30:527–533.
3.
EnerRA, MeglatherySB, Van DeckerWA, GallagherRM: Serotonin syndrome and other serotonergic disorders. Pain Med, 2003; 4:63–74.
4.
AndersonT, WatsonMS, MarrK: Serotonin syndrome: A hidden danger in palliative care. Eur J Palliat Care, 2005; 12:97–100.
5.
DunkleyEJ, IsbisterGK, SibbrittD, DawsonAH, WhyteIM: The hunter serotonin toxicity criteria: Simple and accurate diagnostic decision rules for serotonin toxicity. QJM, 2003; 96:635–642.
6.
SternbachH: The serotonin syndrome. Am J Psychiatry, 1991; 148:705–713.
7.
MojtabaiR, OlfsonM: National trends in long-term use of antidepressant medications: Results from the US National Health and Nutrition Examination Survey. J Clin Psychiatry, 2014; 75:169–177.
8.
JacksonN, DohertyJ, CoulterS: Neuropsychiatric complications of commonly used palliative care drugs. Postgrad Med J, 2008; 84:121–126.
9.
ChristensenRC: Identifying serotonin syndrome in the emergency department. Am J Emerg Med, 2005; 23:406–408.
10.
BirmesP, CoppinD, SchmittL, et al.: Serotonin syndrome: A brief review. CMAJ, 2003; 168:1439–1442.
11.
MillsKC: Serotonin syndrome. A clinical update. Crit Care Clin, 1997; 13:763–783.
12.
BijlD: The serotonin syndrome. Neth J Med, 2004; 62:309–313.
13.
Foong AL, Grindroid KA, Patel T, Kellar J: Demystifying serotonin syndrome Can Fam Physician 2018;64:720–727.
14.
AilawadhiS, SungKW, CarlsonLA, BaerMR: Serotonin syndrome caused by interaction between citalopram and fentanyl. J Clin Pharm Ther, 2007; 32:199–202.
15.
BreivikH: Pain management discussion forum: Serious interaction among frequently used drugs for chronic pain. J Pain Palliat Care Pharmacother, 2014; 28:170–171.
16.
Mateo-CarrascoH, Munoz-AguileraEM, Garcia-TorrecillasJM, Abu Al-RobbH: Serotonin syndrome probably triggered by a morphine-phenelzine interaction. Pharmacother J Hum Pharmacol Drug Ther, 2015; 35:e102–e105.
17.
MeklerG, WoggonB.: A case of serotonin syndrome caused by venlafaxine and lithium. Pharmacopsychiatry, 1997; 30:272–273.
18.
NguyenT, SinB.: A case of an older adult patient and drugs associated with serotonin syndrome. Consultant Pharmacist, 2015; 30:455–458.
19.
OrlovaY, RizzoliP, LoderE.: Association of coprescription of triptan antimigraine drugs and selective serotonin reuptake inhibitor or selective norepinephrine reuptake inhibitor with antidepressants with serotonin syndrome. JAMA Neurol, 2018; 75:566–572.
20.
HaslettCD, KumarS.: Can olanzapine be implicated in causing serotonin syndrome?. Psychiatry Clin Neurosci, 2002; 56:533–535.
21.
MazharF, AkramS, HaiderN, AhmedR.: Overlapping of serotonin syndrome with neuroleptic malignant syndrome due to linezolid-fluoxetine and olanzapine-metoclopramide interactions: A case report of two serious adverse drug effects caused by medication reconciliation failure on hospital admission. Case Rep Med, 2016; 7128909.
22.
VerreM, BossioF, MammoneA, et al.Serotonin syndrome caused by olanzapine and clomipramine. Minerva Anestesiol, 2008; 74:41–45.
23.
MontaneE, BarriocanalA, IsernI, ParajonT, CostaJ.: Multiple drug interactions—Induced serotonin syndrome: A case report. J Clin Pharm Ther, 2009; 34:485–487.
24.
NelsonEM, PhilbrickAM.: Avoiding serotonin syndrome: The nature of the interaction between tramadol and selective serotonin reuptake inhibitors. Ann Pharmacother, 2012; 46:1712–1716.
25.
BakimB, SertcelikS, TankayaO.: A case of serotonin syndrome with antidepressant treatment and concomitant use of the herbal remedy (peganum harmala). Klinik Psikofarmakoloji Bulteni, 2012; 22:359–361.
26.
LantzMS, BuchalterE, GiambancoV.: St John's wort and antidepressant drug interactions in the elderly. J Geriatr Psychiatry Neurol, 1999; 12:7–10.
27.
ClarkDB, AndrusMR, ByrdDC.: Drug interactions between linezolid and selective serotonin reuptake inhibitors: Case report involving sertraline and review of the literature. Pharmacotherapy, 2006; 26:269–276.
28.
wHannaER, ClarkJA.: Serotonin syndrome after cardiopulmonary bypass: A case demonstrating the interaction between methylene blue and selective serotonin reuptake inhibitors. A A Case Rep, 2014; 2:113–114.
29.
GraudinsA, StearmanA, ChanB: Treatment of the serotonin syndrome with cyproheptadine. J Emerg Med, 1998; 16:615–619.